(Q43634789)

25 November 2017

Dipeptidyl peptidase-4 inhibitors and angioedema: a class effect? (English)

1 reference

25 November 2017

Y Saisho

1

1 reference

PubMed ID

23323612

25 November 2017

H Itoh

series ordinal

2

1 reference

25 November 2017

1 April 2013

1 reference

25 November 2017

1 reference

25 November 2017

30

1 reference

25 November 2017

4

1 reference

25 November 2017

e149-50

1 reference

DPP-4 inhibitors: impact on glycemic control and cardiovascular risk factors

25 November 2017

1 reference

Dipeptidyl peptidase-IV inhibitor use associated with increased risk of ACE inhibitor-associated angioedema

21 January 2018

1 reference

Safety and tolerability of sitagliptin in clinical studies: a pooled analysis of data from 10,246 patients with type 2 diabetes

21 January 2018

1 reference

Mechanisms of action of the dipeptidyl peptidase-4 inhibitor vildagliptin in humans

21 January 2018

1 reference

Quantitative model of the relationship between dipeptidyl peptidase-4 (DPP-4) inhibition and response: meta-analysis of alogliptin, saxagliptin, sitagliptin, and vildagliptin efficacy results

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/DME.12134

1 reference

25 November 2017

1 reference

PubMed ID

23323612